Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:GBNH

Greenbrook TMS (GBNH) Stock Price, News & Analysis

Greenbrook TMS logo

About Greenbrook TMS Stock (NASDAQ:GBNH)

Advanced Chart

Key Stats

Today's Range
$0.04
$0.10
50-Day Range
$0.05
$0.38
52-Week Range
$0.10
$1.82
Volume
787,000 shs
Average Volume
3.60 million shs
Market Capitalization
$1.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GBNH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Greenbrook TMS and its competitors with MarketBeat's FREE daily newsletter.

GBNH Stock News Headlines

Neuronetics reports preliminary Q4 revenue $22.1M, consensus $18.98M
Neuronetics Provides Business Update and Issues 2025 Guidance
“All the land that you see I will give to you and your offspring forever…”
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.
Greenbrook TMS Inc (GBNHF)
Greenbrook TMS Strategic Acquisition and Restructuring by Neuronetics
Neuronetics Sees Q3 Revenue Rise Amid Strategic Acquisition
Neuronetics stockholders approve acquisition of Greenbrook TMS
Greenbrook TMS Shareholders Approve Neuronetics Acquisition
See More Headlines

GBNH Stock Analysis - Frequently Asked Questions

Greenbrook TMS Inc. (NASDAQ:GBNH) released its earnings results on Monday, August, 14th. The company reported ($0.30) EPS for the quarter, missing the consensus estimate of ($0.29) by $0.01. The company earned $18.35 million during the quarter, compared to analyst estimates of $19.15 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that Greenbrook TMS investors own include RENN Fund (RCG), Aceragen (ACGN), Alimera Sciences (ALIM), Alpine Summit Energy Partners (ALPS), Angion Biomedica (ANGN), AirMedia Group (ANTE) and Aptorum Group (APM).

Company Calendar

Last Earnings
8/14/2023
Today
7/18/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
N/A
Current Symbol
NASDAQ:GBNH
CIK
1735948
Fax
N/A
Employees
492
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.12)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$61.73 million
Net Margins
-83.19%
Pretax Margin
-83.55%
Return on Equity
N/A
Return on Assets
-66.59%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.47
Quick Ratio
0.47

Sales & Book Value

Annual Sales
$69.10 million
Price / Sales
0.03
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($1.72) per share
Price / Book
-0.03

Miscellaneous

Outstanding Shares
40,800,000
Free Float
31,959,000
Market Cap
$1.96 million
Optionable
Not Optionable
Beta
2.19
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:GBNH) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners